North America Restriction Endonucleases Market by Manufacturers, Countries, Type and Application, Forecast to 2022

April 2017 | 120 pages | ID: NC16254455EEN
GlobalInfoResearch

Abstracts

Restriction Endonuclease is an enzyme that cuts DNA at or near specific recognition nucleotide sequences known as restriction sites. They are the enzymes that are found in the bacteria and are harvested from them for their use in research and commercial aspects. Restriction enzymes are commonly classified into four types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another.

Scope of the Report:

This report focuses on the Restriction Endonucleases in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers

• New England Biolabs
• Thermo Fisher Scientific
• Takara Bio
• Illumina
• Agilent Technologies
• Roche
• GE Healthcare
• Promega Corporation
• Qiagen
• Jena Biosciences

Market Segment by Countries, covering

• United States
• Canada
• Mexico

Market Segment by Type, covers

• Type I
• Type II
• Type III
• Type IV
• Others

Market Segment by Applications, can be divided into

• Academic & Research Institutes
• Hospitals & Diagnostic Centers
• Biopharmaceutical
• Other

There are 15 Chapters to deeply display the North America Restriction Endonucleases market.

Chapter 1, to describe Restriction Endonucleases Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Restriction Endonucleases, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Restriction Endonucleases, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Restriction Endonucleases market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Restriction Endonucleases Research Findings and Conclusion, Appendix, methodology and data source

Contents

1 MARKET OVERVIEW

1.1 Restriction Endonucleases Introduction
1.2 Market Analysis by Type
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
  1.2.4 Type IV
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Academic & Research Institutes
  1.3.2 Hospitals & Diagnostic Centers
  1.3.3 Biopharmaceutical
  1.3.4 Other
1.4 Market Analysis by Countries
  1.4.1 United States Status and Prospect (2012-2022)
  1.4.2 Mexico Status and Prospect (2012-2022)
  1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 New England Biolabs
  2.1.1 Profile
  2.1.2 Restriction Endonucleases Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.1.4 Business Overview
  2.1.5 New England Biolabs News
2.2 Thermo Fisher Scientific
  2.2.1 Profile
  2.2.2 Restriction Endonucleases Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.2.4 Business Overview
  2.2.5 Thermo Fisher Scientific News
2.3 Takara Bio
  2.3.1 Profile
  2.3.2 Restriction Endonucleases Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.3.4 Business Overview
  2.3.5 Takara Bio News
2.4 Illumina
  2.4.1 Profile
  2.4.2 Restriction Endonucleases Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.4.4 Business Overview
  2.4.5 Illumina News
2.5 Agilent Technologies
  2.5.1 Profile
  2.5.2 Restriction Endonucleases Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.5.4 Business Overview
  2.5.5 Agilent Technologies News
2.6 Roche
  2.6.1 Profile
  2.6.2 Restriction Endonucleases Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.6.4 Business Overview
  2.6.5 Roche News
2.7 GE Healthcare
  2.7.1 Profile
  2.7.2 Restriction Endonucleases Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.7.4 Business Overview
  2.7.5 GE Healthcare News
2.8 Promega Corporation
  2.8.1 Profile
  2.8.2 Restriction Endonucleases Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.8.4 Business Overview
  2.8.5 Promega Corporation News
2.9 Qiagen
  2.9.1 Profile
  2.9.2 Restriction Endonucleases Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.9.4 Business Overview
  2.9.5 Qiagen News
2.10 Jena Biosciences
  2.10.1 Profile
  2.10.2 Restriction Endonucleases Type and Applications
    2.10.2.1 Type
    2.10.2.2 Type
  2.10.3 Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  2.10.4 Business Overview
  2.10.5 Jena Biosciences News

3 NORTH AMERICA RESTRICTION ENDONUCLEASES MARKET COMPETITION, BY MANUFACTURER

3.1 North America Restriction Endonucleases Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Restriction Endonucleases Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Restriction Endonucleases Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Restriction Endonucleases Manufacturer Market Share
  3.4.2 Top 5 Restriction Endonucleases Manufacturer Market Share
3.5 Market Competition Trend

4 NORTH AMERICA RESTRICTION ENDONUCLEASES MARKET ANALYSIS BY COUNTRIES

4.1 North America Restriction Endonucleases Sales Market Share by Countries
4.2 North America Restriction Endonucleases Sales by Countries (2012-2017)
4.3 North America Restriction Endonucleases Revenue (Value) by Countries (2012-2017)

5 NORTH AMERICA MARKET SEGMENTATION RESTRICTION ENDONUCLEASES BY TYPE

5.1 North America Restriction Endonucleases Sales, Revenue and Market Share by Type (2012-2017)
  5.1.1 North America Restriction Endonucleases Sales and Market Share by Type (2012-2017)
  5.1.2 North America Restriction Endonucleases Revenue and Market Share by Type (2012-2017)
5.2 Type I Sales Growth and Price
  5.2.1 North America Type I Sales Growth (2012-2017)
  5.2.2 North America Type I Price (2012-2017)
5.3 Type II Sales Growth and Price
  5.3.1 North America Type II Sales Growth (2012-2017)
  5.3.2 North America Type II Price (2012-2017)
5.4 Type III Sales Growth and Price
  5.4.1 North America Type III Sales Growth (2012-2017)
  5.4.2 North America Type III Price (2012-2017)
5.5 Type IV Sales Growth and Price
  5.5.1 North America Type IV Sales Growth (2012-2017)
  5.5.2 North America Type IV Price (2012-2017)
5.6 Others Sales Growth and Price
  5.6.1 North America Others Sales Growth (2012-2017)
  5.6.2 North America Others Price (2012-2017)

6 NORTH AMERICA MARKET SEGMENTATION RESTRICTION ENDONUCLEASES BY APPLICATION

6.1 North America Restriction Endonucleases Sales Market Share by Application (2012-2017)
6.2 Academic & Research Institutes Sales Growth (2012-2017)
6.3 Hospitals & Diagnostic Centers Sales Growth (2012-2017)
6.4 Biopharmaceutical Sales Growth (2012-2017)
6.5 Other Sales Growth (2012-2017)

7 UNITED STATES RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 United States Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Restriction Endonucleases Sales and Market Share by Type
7.3 United States Restriction Endonucleases Sales by Application (2012-2017)
7.4 United States Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer
  7.4.1 United States Restriction Endonucleases Sales and Market Share by Manufacturer
  7.4.2 United States Restriction Endonucleases Revenue and Market Share by Manufacturer
7.5 United States Restriction Endonucleases Export and Import (2012-2017)

8 CANADA RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 Canada Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Restriction Endonucleases Sales and Market Share by Type
8.3 Canada Restriction Endonucleases Sales by Application (2012-2017)
8.4 Canada Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer
  8.4.1 Canada Restriction Endonucleases Sales and Market Share by Manufacturer
  8.4.2 Canada Restriction Endonucleases Revenue and Market Share by Manufacturer
8.5 Canada Restriction Endonucleases Export and Import (2012-2017)

9 MEXICO RESTRICTION ENDONUCLEASES SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Mexico Restriction Endonucleases Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Restriction Endonucleases Sales and Market Share by Type
9.3 Mexico Restriction Endonucleases Sales by Application (2012-2017)
9.4 Mexico Restriction Endonucleases Sales, Revenue and Market Share by Manufacturer
  9.4.1 Mexico Restriction Endonucleases Sales and Market Share by Manufacturer
  9.4.2 Mexico Restriction Endonucleases Revenue and Market Share by Manufacturer
9.5 Mexico Restriction Endonucleases Export and Import (2012-2017)

10 RESTRICTION ENDONUCLEASES MARKET FORECAST (2017-2022)

10.1 North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)
10.2 Restriction Endonucleases Market Forecast by Countries (2017-2022)
  10.2.1 United States Restriction Endonucleases Forecast (2017-2022)
  10.2.2 Canada Restriction Endonucleases Forecast (2017-2022)
  10.2.3 Mexico Restriction Endonucleases Forecast (2017-2022)
10.3 Restriction Endonucleases Market Forecast by Type (2017-2022)
10.4 Restriction Endonucleases Market Forecast by Application (2017-2022)

11 RESTRICTION ENDONUCLEASES MANUFACTURING COST ANALYSIS

11.1 Restriction Endonucleases Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Restriction Endonucleases

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Restriction Endonucleases Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016
12.4 Downstream Buyers

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Restriction Endonucleases Picture
Table Product Specifications of Restriction Endonucleases
Figure North America Sales Market Share of Restriction Endonucleases by Types in 2016
Table Types of Restriction Endonucleases
Figure Type I Picture
Table Major Manufacturers of Type I
Figure Type II Picture
Table Major Manufacturers of Type II
Figure Type III Picture
Table Major Manufacturers of Type III
Figure Type IV Picture
Table Major Manufacturers of Type IV
Figure Others Picture
Table Major Manufacturers of Others
Table North America Restriction Endonucleases Sales Market Share by Applications in 2016
Table Applications of Restriction Endonucleases
Figure Academic & Research Institutes Picture
Figure Hospitals & Diagnostic Centers Picture
Figure Biopharmaceutical Picture
Figure Other Picture
Figure United States Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Restriction Endonucleases Revenue (Million USD) and Growth Rate (2012-2022)
Table New England Biolabs Basic Information, Manufacturing Base and Competitors
Table New England Biolabs Restriction Endonucleases Type and Applications
Table New England Biolabs Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table Thermo Fisher Scientific Restriction Endonucleases Type and Applications
Table Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takara Bio Basic Information, Manufacturing Base and Competitors
Table Takara Bio Restriction Endonucleases Type and Applications
Table Takara Bio Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Illumina Basic Information, Manufacturing Base and Competitors
Table Illumina Restriction Endonucleases Type and Applications
Table Illumina Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table Agilent Technologies Restriction Endonucleases Type and Applications
Table Agilent Technologies Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Restriction Endonucleases Type and Applications
Table Roche Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Restriction Endonucleases Type and Applications
Table GE Healthcare Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Promega Corporation Basic Information, Manufacturing Base and Competitors
Table Promega Corporation Restriction Endonucleases Type and Applications
Table Promega Corporation Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qiagen Basic Information, Manufacturing Base and Competitors
Table Qiagen Restriction Endonucleases Type and Applications
Table Qiagen Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jena Biosciences Basic Information, Manufacturing Base and Competitors
Table Jena Biosciences Restriction Endonucleases Type and Applications
Table Jena Biosciences Restriction Endonucleases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Restriction Endonucleases Sales by Manufacturer (2016-2017)
Figure North America Restriction Endonucleases Sales Market Share by Manufacturer in 2016
Figure North America Restriction Endonucleases Sales Market Share by Manufacturer in 2017
Table North America Restriction Endonucleases Revenue by Manufacturer (2016-2017)
Figure North America Restriction Endonucleases Revenue Market Share by Manufacturer in 2016
Figure North America Restriction Endonucleases Revenue Market Share by Manufacturer in 2017
Table North America Restriction Endonucleases Price by Manufacturers (2016-2017)
Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2016
Figure Top 3 Restriction Endonucleases Manufacturer Market Share in 2017
Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2016
Figure Top 5 Restriction Endonucleases Manufacturer Market Share in 2017
Figure North America Restriction Endonucleases Sales and Growth (2012-2017)
Table North America Restriction Endonucleases Sales by Countries (2012-2017)
Table North America Restriction Endonucleases Sales Market Share by Countries (2012-2017)
Figure North America 2012 Restriction Endonucleases Sales Market Share by Countries
Figure North America 2016 Restriction Endonucleases Sales Market Share by Countries
Figure North America Restriction Endonucleases Revenue and Growth (2012-2017)
Table North America Restriction Endonucleases Revenue by Countries (2012-2017)
Table North America Restriction Endonucleases Revenue Market Share by Countries (2012-2017)
Table North America 2012 Restriction Endonucleases Revenue Market Share by Countries
Table North America 2016 Restriction Endonucleases Revenue Market Share by Countries
Table North America Restriction Endonucleases Sales by Type (2012-2017)
Table North America Restriction Endonucleases Sales Share by Type (2012-2017)
Table North America Restriction Endonucleases Revenue by Type (2012-2017)
Table North America Restriction Endonucleases Revenue Share by Type (2012-2017)
Figure North America Type I Sales Growth (2012-2017)
Figure North America Type I Price (2012-2017)
Figure North America Type II Sales Growth (2012-2017)
Figure North America Type II Price (2012-2017)
Figure North America Type III Sales Growth (2012-2017)
Figure North America Type III Price (2012-2017)
Figure North America Type IV Sales Growth (2012-2017)
Figure North America Type IV Price (2012-2017)
Figure North America Others Sales Growth (2012-2017)
Figure North America Others Price (2012-2017)
Table North America Restriction Endonucleases Sales by Application (2012-2017)
Table North America Restriction Endonucleases Sales Share by Application (2012-2017)
Figure North America Academic & Research Institutes Sales Growth (2012-2017)
Figure North America Hospitals & Diagnostic Centers Sales Growth (2012-2017)
Figure North America Biopharmaceutical Sales Growth (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure United States Restriction Endonucleases Revenue and Growth (2012-2017)
Figure United States Restriction Endonucleases Sales and Growth (2012-2017)
Table United States Restriction Endonucleases Sales by Type (2012-2017)
Table United States Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table United States Restriction Endonucleases Sales by Application (2012-2017)
Table United States Restriction Endonucleases Sales Market Share by Application (2012-2017)
Table United States Restriction Endonucleases Sales by Manufacturer (2016-2017)
Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2016
Figure United States Restriction Endonucleases Sales Market Share by Manufacturer in 2017
Table United States Restriction Endonucleases Revenue by Manufacturer (2016-2017)
Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2016
Figure United States Restriction Endonucleases Revenue Market Share by Manufacturer in 2017
Table United States Restriction Endonucleases Export and Import (2012-2017)
Figure Canada Restriction Endonucleases Revenue and Growth (2012-2017)
Figure Canada Restriction Endonucleases Sales and Growth (2012-2017)
Table Canada Restriction Endonucleases Sales by Type (2012-2017)
Table Canada Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table Canada Restriction Endonucleases Sales by Application (2012-2017)
Table Canada Restriction Endonucleases Sales Market Share by Application (2012-2017)
Table Canada Restriction Endonucleases Sales by Manufacturer (2016-2017)
Figure Canada Restriction Endonucleases Sales Market Share by Manufacturer in 2016
Figure Canada Restriction Endonucleases Sales Market Share by Manufacturer in 2017
Table Canada Restriction Endonucleases Revenue by Manufacturer (2016-2017)
Figure Canada Restriction Endonucleases Revenue Market Share by Manufacturer in 2016
Figure Canada Restriction Endonucleases Revenue Market Share by Manufacturer in 2017
Table Canada Restriction Endonucleases Export and Import (2012-2017)
Figure Mexico Restriction Endonucleases Revenue and Growth (2012-2017)
Figure Mexico Restriction Endonucleases Sales and Growth (2012-2017)
Table Mexico Restriction Endonucleases Sales by Type (2012-2017)
Table Mexico Restriction Endonucleases Sales Market Share by Type (2012-2017)
Table Mexico Restriction Endonucleases Sales by Application (2012-2017)
Table Mexico Restriction Endonucleases Sales Market Share by Application (2012-2017)
Table Mexico Restriction Endonucleases Sales by Manufacturer (2016-2017)
Figure Mexico Restriction Endonucleases Sales Market Share by Manufacturer in 2016
Figure Mexico Restriction Endonucleases Sales Market Share by Manufacturer in 2017
Table Mexico Restriction Endonucleases Revenue by Manufacturer (2016-2017)
Figure Mexico Restriction Endonucleases Revenue Market Share by Manufacturer in 2016
Figure Mexico Restriction Endonucleases Revenue Market Share by Manufacturer in 2017
Table Mexico Restriction Endonucleases Export and Import (2012-2017)
Figure North America Restriction Endonucleases Sales, Revenue and Growth Rate (2017-2022)
Table North America Restriction Endonucleases Sales Forecast by Countries (2017-2022)
Table North America Restriction Endonucleases Market Share Forecast by Countries (2017-2022)
Figure United States Restriction Endonucleases Sales Forecast (2017-2022)
Figure Canada Restriction Endonucleases Sales Forecast (2017-2022)
Figure Mexico Restriction Endonucleases Sales Forecast (2017-2022)
Table North America Restriction Endonucleases Sales Forecast by Type (2017-2022)
Table North America Restriction Endonucleases Market Share Forecast by Type (2017-2022)
Table North America Restriction Endonucleases Sales Forecast by Application (2017-2022)
Table North America Restriction Endonucleases Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Restriction Endonucleases
Figure Manufacturing Process Analysis of Restriction Endonucleases
Figure Restriction Endonucleases Industrial Chain Analysis
Table Raw Materials Sources of Restriction Endonucleases Major Manufacturers in 2016
Table Major Buyers of Restriction Endonucleases
Table Distributors/Traders/ Dealers List